|
|
|
|
LEADER |
01297nam a2200277 u 4500 |
001 |
EB001872355 |
003 |
EBX01000000000000001035726 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
190824 r ||| eng |
245 |
0 |
0 |
|a Implantable defibrillator
|h Elektronische Ressource
|
260 |
|
|
|a Stockholm, Sweden
|b SBU-Swedish Council on Health Technology Assessment
|c [2006], 2006
|
300 |
|
|
|a 1 PDF file (2 pages)
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Defibrillators, Implantable
|
653 |
|
|
|a Evidence-Based Medicine
|
653 |
|
|
|a Arrhythmias, Cardiac / prevention & control
|
710 |
2 |
|
|a Statens beredning för medicinsk utvärdering (Sweden)
|
740 |
0 |
2 |
|a Implanterbar defibrillator
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a SBU alert report
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK447980
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 580
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a Conclusions There is strong scientific evidence that implantable cardioverter defibrillator (ICD) treatment aimed at secondary prevention leads to lower mortality. There is moderately strong scientific evidence that ICD treatment aimed at primary prevention leads to lower mortality
|